Article about Harburg's contribution to vaccine production published in the December issue of Buisness and People magazine.

The magazine article reports on the Institute's work on the efficient production of biotechnological/pharmaceutical products, such as the current vaccines for corona prevention. A small insight is given into how the scaling up from laboratory scale to production scale is done.